Macroamylasemia as a Rare Cause of Hyperamylasemia: A Case Report
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Macroamylasemia is a rare condition characterized by the formation of an amylase–globulin complex that is too large to be readily excreted by the kidneys and leads to elevated serum amylase levels. It is a benign condition lack-ing severe signs and symptoms that does not require treatment. This paper presents a case of a middle-aged man with unexplained elevated serum amylase levels. Despite an initially elevated triglyceride level, clinical findings, laboratory test results, and radiological findings were not suggestive of pancreatitis. The ratio of renal amylase clear-ance to creatinine clearance was calculated at <1%, consistent with macroamylasemia. No specific treatment was given, and he was monitored periodically. Nevertheless, macroamylasemia is a diagnostic challenge because of the need to differentiate it from other causes of hyperamylasemia to avoid unnecessary tests and treatments.
Abstract
Macroamylasemia is a rare condition characterized by the formation of an amylase–globulin complex that is too large to be readily excreted by the kidneys and leads to elevated serum amylase levels. It is a benign condition lack-ing severe signs and symptoms that does not require treatment. This paper presents a case of a middle-aged man with unexplained elevated serum amylase levels. Despite an initially elevated triglyceride level, clinical findings, laboratory test results, and radiological findings were not suggestive of pancreatitis. The ratio of renal amylase clear-ance to creatinine clearance was calculated at <1%, consistent with macroamylasemia. No specific treatment was given, and he was monitored periodically. Nevertheless, macroamylasemia is a diagnostic challenge because of the need to differentiate it from other causes of hyperamylasemia to avoid unnecessary tests and treatments.
참고문헌 (11)
- Lam R, "Hyperamylasemia" (2021), StatPearls Publishing
- Salt WB 2nd, "Amylase : its clinical significance : a review of the literature", Medicine(Baltimore), 55, pp.269~289 (1976)
- Tseng Y, "Asymptomatic hyperamylasemia in Stevens-Johnson syndrome is associated with intestinal barrier dysfunction", Biomed Res Int, 2020, pp.3531907~ (2020)
- LeVine D, "Macroamylasemia : a simple stepwise approach to diagnosis", J Am Board Fam Pract, 2, pp.279~282 (1989)
- Klonoff DC, "Macroamylasemia and other immunoglobulin-complexed enzyme disorders", West J Med, 133, pp.392~407 (1980)
- Sturk A, "Macro enzymes : prevalence, composition, detection and clinical relevance", J Clin Chem Clin Biochem, 28, pp.65~81 (1990)
- Joksimovic Z, "Macroamylasemia as a cause of hyperamylasemia in clinically unclear conditions : case report", Timoc Med Glas, 45, pp.68~72 (2020)
- Simac DV, "Diagnosing macroamylasemia in unexplained hyperamylasemia", Acta Med Croatica, 71, pp.63~66 (2017)
- Fujimura Y, "Macroamylasemia associated with ulcerative colitis", J Mol Med(Berl), 73, pp.95~97 (1995)
- Depsames R, "Macroamylasemia as the first manifestation of celiac disease", Case Rep Gastroenterol, 2, pp.196~198 (2008)
- Garg R, "Management of hypertriglyceridemia induced acute pancreatitis", Biomed Res Int, 2018, pp.4721357~ (2018)